In 2025, Innovent Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), Scope 2 (indirect emissions from purchased energy) and Scope 3 (indirect emissions across the value chain).
However, Innovent Biologics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.
| Metric (tCO2e) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Scope 1 | 7,802.76a | 47.78b | 65.17c | |
Total Scope 2 | ||||
Unspecified Calculation Method | N/A | 14,067.51b | 15,829.25c | |
Total Scope 3 | 19,460.43a | N/A | N/A | |
Total Scope 1 Revenue Intensity (tCO2e/$M) | 4.1886a | 0.037b | 0.0746c |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, the total operational greenhouse gas (GHG) emissions of Innovent Biologics amounted to 82,488.02 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a
Compared to 2024, the total operational greenhouse gas (GHG) emissions of Innovent Biologics increased by 484.39%, suggesting that the company faced challenges in reducing its emissions from its core operations.ab
In 2025, the total Scope 1 emissions of Innovent Biologics were 7,802.76 metric tons of CO₂ equivalent (tCO₂e).a
Since 2022, Innovent Biologics's Scope 1 emissions have increased by 11,591.28%, reflecting a rising long-term trend in Scope 1 emissions over time.ad
Compared to the previous year (2024), Innovent Biologics's Scope 1 emissions increased by 16,230.6%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations.ab
In 2025, Innovent Biologics reported Scope 2 greenhouse gas (GHG) emissions of 74,685.26 tCO₂e using the location-based method.a
In 2025, Innovent Biologics reported its Scope 2 emissions using the location-based method.a
In 2025, Innovent Biologics reported 19,460.43 metric tons of CO₂ equivalent (tCO₂e) of Scope 3 greenhouse gas (GHG) emissions, representing indirect emissions across its upstream and downstream value chain.a
The 2025 disclosure of Innovent Biologics includes a breakdown across 0 of the 15 Scope 3 categories defined by the GHG Protocol, matching the level of disclosure in 2024, demonstrating consistent Scope 3 emissions reporting coverage year over year.a
In 2025, Innovent Biologics reported total Scope 3 emissions of 19,460.43 metric tons of CO₂ equivalent (tCO₂e).a
In 2025, Innovent Biologics reported Scope 1 greenhouse gas (GHG) emissions of 7,802.76 tCO₂e and total revenues of USD 1,863 millions. This translates into an emissions intensity of 4.19 tCO₂e per millions USD.a
In 2025, Innovent Biologics reported a Scope 1 emissions intensity of 4.19 tCO₂e per millions USD. Compared to the peer group median of 13.51, this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors.a
In 2025, Innovent Biologics ranked 8 out of 23 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD).a
Innovent Biologics is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency.a
In 2025, Innovent Biologics reported a total carbon footprint of 101,948.45 metric tons of CO₂ equivalent (tCO₂e) across Scope 1, Scope 2, and Scope 3 emissions. This represents a 622.26% increase compared to 2024, suggesting a rise in emissions across its operations or value chain.ab
The largest contributor to Innovent Biologics's total carbon footprint was Scope 2 emissions, accounting for 73.26% of the company's total carbon footprint, followed by Scope 3 emissions at 19.09%.a